Business Context and Reporting Period
Company: Harvard Bioscience, Inc. (HBIO)
Filing Type: Form 8-K (Current Report)
Date of Report: July 25, 2019
Reporting Period: The filing announces financial results for the three and six months ended June 30, 2019.
Key Financial Metrics
The provided text is a cover sheet for a Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, the filing text does not provide clear values for these metrics.
Material Changes
No material changes or comparative financial data are disclosed within the body of this specific filing text. The document serves solely to notify the SEC of the issuance of a press release regarding the company's results of operations and financial condition.
Guidance, Outlook, and Management Commentary
Management Action: On July 25, 2019, the company issued a press release and scheduled a conference call for 4:30 PM EST to discuss the results.
Legal Disclaimer: The information in Item 2.02 and the attached press release is furnished but not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section unless expressly incorporated by reference in another filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net income, and cash flow figures for the periods ended June 30, 2019.
- Verify the details of the conference call held on July 25, 2019, for management commentary on future outlook and risks.
- Confirm whether the press release contains updated guidance or material risk factors not present in prior filings.
- Check subsequent filings to see if the results were formally incorporated by reference into other SEC documents.